Alivus Life

{
  "main_header": {
    "sid": 1003513,
    "name": "Alivus Life",
    "stock_name": "Alivus Life",
    "full_name": "Alivus Life Sciences Ltd",
    "name_url": "stocks-analysis/alivus-life",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,064.05",
    "chg": -9.1,
    "chgp": "-0.85%",
    "dir": -1,
    "prev_price": "1,073.15",
    "mcapval": "13,118.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543322,
    "symbol": "ALIVUS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE03Q201024",
    "curr_date": "Apr 17",
    "curr_time": "",
    "bse_nse_vol": "2.24 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 17, 2026",
    "traded_date_str": "2026 04 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alivus-life-1003513-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Alivus Life Sciences Gains 2.25%: Technical Upgrades and Strong Quarterly Results Drive Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-gains-225-technical-upgrades-and-strong-quarterly-results-drive-momentum-3952199",
        "imagepath": "",
        "date": "2026-04-18 11:03:42",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>13 Apr:</strong> Mojo Grade upgraded to Buy on strong technical and financial performance</p>\n                    <p><strong>13 Apr:</strong> Technical momentum shifts signal bullish outlook</p>\n                    <p><strong>17 Apr:</strong> Stock closes at Rs.1,066.65, down 0.61% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,043.20</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,066.65</div><div class=\"stat-change positive\">+2.25%</div></div>\n                    ..."
      },
      {
        "title": "Alivus Life Sciences Ltd Upgraded to Buy on Strong Technical and Financial Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-upgraded-to-buy-on-strong-technical-and-financial-performance-3944205",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlivusLifeScien_mojoScore_3944205.png",
        "date": "2026-04-13 08:24:16",
        "description": "Alivus Life Sciences Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 10 April 2026, underscores the company’s robust quarterly results, bullish technical signals, and consistent long-term returns that have outpaced broader market benchmarks."
      },
      {
        "title": "Alivus Life Sciences Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-technical-momentum-shifts-signal-bullish-outlook-3944076",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlivusLifeScien_technicaldot_3944076.png",
        "date": "2026-04-13 08:04:18",
        "description": "Alivus Life Sciences Ltd has recently experienced a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish trend. Supported by positive signals from key indicators such as MACD, Bollinger Bands, and moving averages, the small-cap pharmaceutical company is demonstrating strength in price action and market sentiment, outperforming broader benchmarks over multiple timeframes."
      },
      {
        "title": "Alivus Life Sciences Gains 3.79%: 3 Key Technical Shifts Drive Weekly Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-gains-379-3-key-technical-shifts-drive-weekly-momentum-3942566",
        "imagepath": "",
        "date": "2026-04-11 11:03:45",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>6 Apr:</strong> Week opens at Rs.1,005.10</p>\n                    <p><strong>7 Apr:</strong> Technical momentum shifts amid mixed indicator signals</p>\n                    <p><strong>8 Apr:</strong> Technical momentum upgrades to mildly bullish with strong returns</p>\n                    <p><strong>10 Apr:</strong> Golden Cross formation signals potential bullish breakout</p>\n                    <p><strong>10 Apr:</strong> Week closes at Rs.1,043.20 (+3.79%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,005.10</div></div>\n                    <div cla..."
      },
      {
        "title": "Golden Cross Confirmed: Do Alivus Life Sciences Ltd's Other Technical Indicators Agree?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-forms-golden-cross-signalling-potential-bullish-breakout-3942046",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlivusLifeScien_goldencross_3942046.png",
        "date": "2026-04-10 18:00:37",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Alivus Life Sciences Ltd, signalling a golden cross on 10 Apr 2026. While this technical event often suggests a shift towards bullish momentum, the broader technical and fundamental context presents a nuanced picture that merits closer examination."
      },
      {
        "title": "Alivus Life Sciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-is-rated-hold-3937562",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlivusLifeScien_mojoScore_3937562.png",
        "date": "2026-04-08 10:10:03",
        "description": "Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 21 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 April 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Alivus Life Sciences Ltd Shows Technical Momentum Shift Amid Strong Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-shows-technical-momentum-shift-amid-strong-returns-3936478",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlivusLifeScien_technicaldot_3936478.png",
        "date": "2026-04-08 08:03:55",
        "description": "Alivus Life Sciences Ltd has demonstrated a notable shift in technical momentum, moving from a mildly bearish stance to a mildly bullish outlook. This transition is supported by a combination of technical indicators including MACD, Bollinger Bands, and moving averages, signalling a potential uptrend for the pharmaceuticals and biotechnology small-cap stock."
      },
      {
        "title": "Why is Alivus Life Sciences Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-alivus-life-sciences-ltd-fallingrising-3936209",
        "imagepath": "",
        "date": "2026-04-08 01:33:36",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Robust Financial Performance Underpins Price Gains</strong></p>\n<p>Alivus Life Sciences has demonstrated impressive financial results in its latest quarterly report ending December 2025. The company recorded its highest-ever net sales at ₹672.89 crores, accompanied by a peak PBDIT of ₹231.28 crores. This translated into an operating profit margin of 34.37%, marking the strongest quarterly operating efficiency in its history. Such robust profitability metrics have reinforced investor confidence in the company’s operational capabilities and growth trajectory.</p>\n<p>Moreover, the company’s return on equity (ROE) stands at a healthy 18.73%, signalling effective management utilisation of shareholder funds. This level of ROE, combined with a zero average debt-to-equity ratio, highlights Alivus Li..."
      },
      {
        "title": "Alivus Life Sciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3935572",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlivusLifeScien_technicaldot_3935572.png",
        "date": "2026-04-07 08:05:39",
        "description": "Alivus Life Sciences Ltd has experienced a notable shift in its technical momentum, with recent indicators signalling a transition from a sideways trend to a mildly bearish stance. Despite a 3.08% gain on 7 April 2026, the stock’s technical parameters present a complex picture, reflecting both bullish and bearish signals across weekly and monthly timeframes."
      }
    ],
    "total": 274,
    "sid": "1003513",
    "stock_news_url": "https://www.marketsmojo.com/news/alivus-life-sciences-1003513"
  },
  "announcements": [
    {
      "caption": "Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015",
      "datetime": "21-Mar-2026",
      "details": "Kindly refer attachment.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "12-Mar-2026",
      "details": "Disclosure under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meeting",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "06-Mar-2026",
      "details": "Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meeting",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alivus Life Sciences Ltd has declared <strong>250%</strong> dividend, ex-date: 01 Sep 25",
          "dt": "2025-09-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Alivus Life Sciences Gains 2.25%: Technical Upgrades and Strong Quarterly Results Drive Momentum

2026-04-18 11:03:42

Key Events This Week

13 Apr: Mojo Grade upgraded to Buy on strong technical and financial performance

13 Apr: Technical momentum shifts signal bullish outlook

17 Apr: Stock closes at Rs.1,066.65, down 0.61% on the day

Week Open

Rs.1,043.20

Week Close

Rs.1,066.65

+2.25%

...

Read full news article

Alivus Life Sciences Ltd Upgraded to Buy on Strong Technical and Financial Performance

2026-04-13 08:24:16

Alivus Life Sciences Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 10 April 2026, underscores the company’s robust quarterly results, bullish technical signals, and consistent long-term returns that have outpaced broader market benchmarks.

Read full news article

Alivus Life Sciences Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-04-13 08:04:18

Alivus Life Sciences Ltd has recently experienced a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish trend. Supported by positive signals from key indicators such as MACD, Bollinger Bands, and moving averages, the small-cap pharmaceutical company is demonstrating strength in price action and market sentiment, outperforming broader benchmarks over multiple timeframes.

Read full news article

Alivus Life Sciences Gains 3.79%: 3 Key Technical Shifts Drive Weekly Momentum

2026-04-11 11:03:45

Key Events This Week

6 Apr: Week opens at Rs.1,005.10

7 Apr: Technical momentum shifts amid mixed indicator signals

8 Apr: Technical momentum upgrades to mildly bullish with strong returns

10 Apr: Golden Cross formation signals potential bullish breakout

10 Apr: Week closes at Rs.1,043.20 (+3.79%)

Week Open

Rs.1,005.10

Read full news article

Golden Cross Confirmed: Do Alivus Life Sciences Ltd's Other Technical Indicators Agree?

2026-04-10 18:00:37

The 50-day moving average has crossed above the 200-day moving average for Alivus Life Sciences Ltd, signalling a golden cross on 10 Apr 2026. While this technical event often suggests a shift towards bullish momentum, the broader technical and fundamental context presents a nuanced picture that merits closer examination.

Read full news article

Alivus Life Sciences Ltd is Rated Hold

2026-04-08 10:10:03

Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 21 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Alivus Life Sciences Ltd Shows Technical Momentum Shift Amid Strong Returns

2026-04-08 08:03:55

Alivus Life Sciences Ltd has demonstrated a notable shift in technical momentum, moving from a mildly bearish stance to a mildly bullish outlook. This transition is supported by a combination of technical indicators including MACD, Bollinger Bands, and moving averages, signalling a potential uptrend for the pharmaceuticals and biotechnology small-cap stock.

Read full news article

Why is Alivus Life Sciences Ltd falling/rising?

2026-04-08 01:33:36

Robust Financial Performance Underpins Price Gains

Alivus Life Sciences has demonstrated impressive financial results in its latest quarterly report ending December 2025. The company recorded its highest-ever net sales at ₹672.89 crores, accompanied by a peak PBDIT of ₹231.28 crores. This translated into an operating profit margin of 34.37%, marking the strongest quarterly operating efficiency in its history. Such robust profitability metrics have reinforced investor confidence in the company’s operational capabilities and growth trajectory.

Moreover, the company’s return on equity (ROE) stands at a healthy 18.73%, signalling effective management utilisation of shareholder funds. This level of ROE, combined with a zero average debt-to-equity ratio, highlights Alivus Li...

Read full news article

Alivus Life Sciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-04-07 08:05:39

Alivus Life Sciences Ltd has experienced a notable shift in its technical momentum, with recent indicators signalling a transition from a sideways trend to a mildly bearish stance. Despite a 3.08% gain on 7 April 2026, the stock’s technical parameters present a complex picture, reflecting both bullish and bearish signals across weekly and monthly timeframes.

Read full news article

View All News